Emergent BioSolutions (NYSE:EBS) will manufacture doses of Providence Therapeutics' PTX-COVID19-B COVID-19 mRNA drug candidate under a five-year agreement. The agreement…
Rockville, MD, September 13, 2021 – The U.S. Pharmacopeia (USP) announces the launch of a new department, the Office of Organizational Culture, Equity and Inclusive Excellence (Equity Office). Headed by Chief Equity Officer (CEqO) and…